ArticlePloS one2017

Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.

Mark T Winkler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.